Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
Funds basic research on the harm caused by a single exposure to ultra-potent synthetic opioids, including the effects that appear later.
Fentanyl, carfentanil and the nitazenes are potent enough that a single exposure is a medical emergency, and increasingly they arrive mixed with something else. This notice funds understanding what that exposure actually does.
Two strands are named. Understanding and mitigating the harmful effects of acute exposure to ultra-potent synthetic opioids and their combinations — the notice gives fentan…
Basic research on understanding and mitigating the deleterious effects of acute exposure to ultra-potent synthetic opioids including fentanyl, carfentanil and nitazenes, and their combinations such as fentanyl with xylazine, and on persistent or delayed pathophysiological effects following acute exposure. Clinical trials are not allowed.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up